Furthermore, BTZ demonstrated antitumor activity against nasopharyngeal carcinoma (NPC) cells, while in-vitro and in combination with the suberoylanilide hydroxamic potently induces apoptosis and suppresses the growth of NPC in mouse model [127,128]. Here, CASC3 is linked to nasopharyngeal carcinoma.